Lilly settles most remaining Zyprexa claims
Eli Lilly and Co. has agreed to settle most of the remaining liability claims against its Zyprexa schizophrenia drug, the Indianapolis drug maker announced this morning. The agreement covers about 18,000 people. Lilly did not disclose the cost of the settlement, but said the total amount is “substantially less” than the $700 million it […]